| Revenue growth | Value |
|---|---|
| 3Y CAGR | +28% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +131% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,870.40 -107.80 (2.17%) | 22,759.95 | 30.96 | 5.42 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,495.00 -65.80 (2.57%) | 19,444.55 | 28.68 | 5.42 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,210.00 -205.50 (2.77%) | 18,526.25 | 109.22 | 21.23 | ||
Natco PharmaNATCOPHARM | ₹881.00 -1.40 (0.16%) | 15,806.45 | 13.81 | 1.71 |